Chlamydia pneumoniae, IgG, IgM, IgA
Use
This test employs immunofluorescence to detect IgM, IgG, and IgA antibodies to Chlamydia pneumoniae in human serum. C pneumoniae has been implicated as one of the agents of atypical pneumonia and may be responsible for as many as 10% of all hospitalized and outpatient cases of pneumonia. Additionally, it may also be responsible for sinusitis and otitis.
Special Instructions
Not provided.
Limitations
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary. Results of this test are for investigational purposes only. The result should not be used as a diagnostic procedure without confirmation of the diagnosis by another medically established diagnostic product or procedure.
Methodology
Immunoassay (Immunofluorescence)
Biomarkers
LOINC Codes
- 139317
- 6913-8
- 6914-6
- 6912-0
Result Turnaround Time
1-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.5 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Refrigerate. Per the package insert: Samples are stable at room temperature for eight hours. After eight hours, samples should be refrigerated at 2° to 8° C for up to 48 hours. After 48 hours, freeze samples at -20° C or colder.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 8 hours |
| Refrigerated | 48 hours |
| Frozen | indefinite |